1 / 8

Collecting Site Positivity Data in Region I

Collecting Site Positivity Data in Region I. Andee Krasner, MPH Region I IPP Advisory Board Meeting. Background. In 2006, Region I began collecting only IPP-funded CT testing data

simmonse
Download Presentation

Collecting Site Positivity Data in Region I

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

  2. Background • In 2006, Region I began collecting only IPP-funded CT testing data • In 2010, CDC requested that the Infrastructure begin process of collecting site CT data, not just IPP-funded CT Testing

  3. Goals • With minimum burden to IPP AB Members, collect site positivity for IPP-funded sites and report to CDC • Make site positivity data available through state IPP Prevalence Monitoring System for use at state and local level

  4. CSPS- 3% Minimum • CSPS guidance assumes site positivity, not IPP positivity • Not known how IPP positivity rates compare to site positivity • If you have site positivity data, you should use it to determine 3% minimum positivity requirements for CSPS • May use IPP positivity rates for CSPS until site positivity project is complete

  5. Plan for Collecting Site Positivity • Work with State STD Directors and Lab Directors to request data extracts for data already collected by the state • Work with STD Directors and Family Planning Directors to request data from private labs • Develop systems for feeding site positivity data back into Prevalence Monitoring Data Systems

  6. Requested Data Fields • Request limited dataset from Labs: • Medical Record # / (Lab ID # will be ok) • Test Facility ID • State of Client residence (zip is ok) • Age (DOB is ok) • Gender • Test for CT and/or GC • Test result • Date of test performed • Nice to have: • Race/Ethnicity • Clinical History (source, pregnant, routine exam) • Payment • Risk History

  7. Progress • RI – provided data extract for all tests from IPP sites • PPNNE – provided data extract from all PPNNE IPP sites in VT, NH and ME • NH State Lab going to an electronic reporting system. They will provide extract of all state-funded tests at IPP sites.

  8. Next Steps • Non-IPP funded tests received • Develop a system for feeding data back into state Prevalence Monitoring System • Work with AB Members to request limited dataset from IPP sites • New Hampshire • Maine • Connecticut • Massachusetts

More Related